HCA Healthcare price target raised to $425 from $400 at Morgan Stanley

Morgan Stanley raised the firm’s price target on HCA Healthcare (HCA) to $425 from $400 and keeps an Equal Weight rating on the shares. Q3 results “underscore solid execution,” but “it may be time for a breather” following a strong run up in the stock, the analyst tells investors in a post-earnings note. With the stock up 30% since the Q2 report in late July, the stock could consolidate, though HCA is executing well and remains a bellwether in the group, the analyst added.